Switching from high-fat diet to foods containing resveratrol as a calorie restriction mimetic changes the architecture of arcuate nucleus to produce more newborn anorexigenic neurons
- 98 Downloads
These days, obesity threatens the health for which one of the main interventions is calorie restriction (CR). Due to the difficulty of compliance with this treatment, CR mimetics such as resveratrol (RSV) have been considered. The present study compared the effects of RSV and CR on hypothalamic remodeling in a diet-switching experiment.
C57BL/6 male mice received high-fat diet (HFD) for 4 weeks, subsequently their diet switched to chow diet, HFD + RSV, chow diet + RSV or CR diet for a further 6 weeks. Body weight, fat accumulation, hypothalamic apoptosis and expression of trophic factors as well as generation and fate specification of newborn cells in arcuate nucleus (ARC) were evaluated.
Switching diet to RSV-containing foods leading to weight and fat loss after 6 weeks. In addition, not only a significant reduction in apoptosis but also a considerable increase in production of newborn cells in ARC occurred following consumption of RSV-enriched diets. These were in line with augmentation of hypothalamic ciliary neurotrophic factor and leukemia inhibitory factor expression. Interestingly, RSV-containing diets changed the fate of newborn neurons toward generation of more proopiomelanocortin than neuropeptide Y neurons. The CR had effects similar to those of RSV-containing diets in the all-evaluated aspects besides neurogenesis in ARC.
Although both RSV-containing and CR diets changed the fate of newborn neurons to create an anorexigenic architecture for ARC, newborn neurons were more available after switching to RSV-enriched diets. It can be consider as a promising mechanism for future investigations.
KeywordsResveratrol Hypothalamus Obesity Calorie restriction High-fat diet Neurogenesis
This investigation was supported by Tehran University of Medical Sciences and Health Services (Grant No. 93-01-161-25558), we wish to thank the Shefa Neuroscience Research Center scientists and staff.
Compliance with ethical standards
Conflict of interest
The authors have declared no conflicts of interest.
- 5.Heilbronn LK, de Jonge L, Frisard MI, DeLany JP, Larson-Meyer DE, Rood J, Nguyen T, Martin CK, Volaufova J, Most MM (2006) Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA 295(13):1539–1548CrossRefGoogle Scholar
- 6.Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, Goossens GH, Hoeks J, van der Krieken S, Ryu D, Kersten S (2011) Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 14(5):612–622CrossRefGoogle Scholar
- 9.Wang S, Zhu M-J, Du M (2015) Prevention of obesity by dietary resveratrol: how strong is the evidence? Taylor & Francis, LondonGoogle Scholar
- 23.Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ (2007) Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Prev Biomark 16(6):1246–1252CrossRefGoogle Scholar
- 24.Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, Vasilinin G, Sen A, Schinas AM, Piccirilli G (2010) Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res 70(22):9003–9110CrossRefGoogle Scholar
- 25.Van Itallie TB (1978) Dietary fiber and obesity. Am J Clin Nutr 31(10):S43-S52Google Scholar
- 33.Belvindrah R, Lazarini F, Lledo P-M (2009) Postnatal neurogenesis: from neuroblast migration to integration into mature circuits. Rev Neurosci 20(5–6):331–346Google Scholar
- 50.Lambert P, Anderson K, Sleeman M, Wong V, Tan J, Hijarunguru A, Corcoran T, Murray J, Thabet K, Yancopoulos G (2001) Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity. Proc Natl Acad Sci 98(8):4652–4657CrossRefGoogle Scholar